APRE - Aprea Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - APRE (1781983)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
7 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-13
APREHamill John P.SrVP, CFO, Prin Fin, Acct OfcrP - Purchase$7.29+1,01015,503+7%+$7,363
D
2024-03-13
APRESeizinger Bernd R.DirP - Purchase$7.29+6,86033,685+26%+$50,009
D
2024-03-13
APREHenneman John B IIIDirP - Purchase$7.29+6,8608,139+536%+$50,009
D
2024-03-13
APREGilad OrenPres, CEOP - Purchase$7.29+2,000324,770+1%+$14,580
M
2023-06-06
APRESeizinger Bernd R.DirP - Purchase$3.66+10,09726,325+62%+$36,957
2022-05-18
APRESeizinger Bernd R.DirP - Purchase$0.71+50,000318,580+19%+$35,500
2022-05-18
APRESchade Christian SCOB, CEOP - Purchase$0.64+37,500303,616+14%+$24,124

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top